Alto Neuroscience, Inc. (ANRO) Financial Statements

565 Followers

Alto Neuroscience, Inc. Financial Overview

Alto Neuroscience, Inc.'s market cap is currently $821.32M. The company's EPS TTM is $-0.46; its P/E ratio is -8.12; Alto Neuroscience, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 210.00K
Gross Profit	$ -661.00K	$ -502.00K	$ -373.00K	$ -342.00K	$ 65.00K
Operating Income	$ -66.36M	$ -68.61M	$ -37.81M	$ -29.19M	$ -12.06M
EBITDA	$ -65.70M	$ -68.61M	$ -34.56M	$ -27.37M	$ -9.04M
Net Income	$ -63.24M	$ -61.43M	$ -36.30M	$ -27.71M	$ -9.19M
Balance Sheet
Cash & Short-Term Investments	$ 176.48M	$ 168.23M	$ 82.55M	$ 48.34M	$ 25.70M
Total Assets	$ 184.69M	$ 177.54M	$ 86.63M	$ 50.85M	$ 28.79M
Total Debt	$ 4.41M	$ 16.94M	$ 9.99M	$ 82.11M	$ 38.16M
Net Debt	$ -172.08M	$ -151.28M	$ -72.56M	$ 33.76M	$ 12.46M
Total Liabilities	$ 33.55M	$ 26.08M	$ 158.30M	$ 89.26M	$ 41.27M
Stockholders' Equity	$ 151.14M	$ 151.46M	$ -71.67M	$ -38.41M	$ -12.48M
Cash Flow
Free Cash Flow	$ -51.79M	$ -49.50M	$ -33.92M	$ -21.13M	$ -9.94M
Operating Cash Flow	$ -51.77M	$ -47.42M	$ -33.45M	$ -20.39M	$ -9.26M
Investing Cash Flow	$ -24.00K	$ -2.08M	$ -470.00K	$ -732.00K	$ -680.00K
Financing Cash Flow	$ 60.08M	$ 135.69M	$ 68.13M	$ 43.79M	$ 31.69M

Currency in USD

Alto Neuroscience, Inc. Earnings and Revenue History

Income Statement >

Alto Neuroscience, Inc. Debt to Assets

Balance Sheet >

Alto Neuroscience, Inc. Cash Flow

Cash Flow >

Alto Neuroscience, Inc. Forecast EPS vs Actual EPS

Earnings >